NL-OMON27516招募中不适用
Documenting the 'critical view of safety': Photograph or video.
niversity Medical Center GroningenPost Box 30.0019700 RB Groningen0031 50 36161610 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. >17 years old;
- •2. Laparoscopic cholecystectomy.
排除标准
- •Conversion before the 'critical view of safety' is reached.
研究者
相似试验
已完成
4 期
To evaluate safety and performance of Drug Eluting Stent and Bare Metal Stent in the treatment of patients with coronary artery blockage.CTRI/2017/11/010531Meril Life Sciences Pvt Ltd750
已完成
不适用
Operational Evaluation of a Photic Countermeasure to Improve Alertness, Performance, and Mood During Nightshift Work on a 105-day Simulated Human Exploration Mission to MarsSleepAlertnessFatigueNCT01169233Brigham and Women's Hospital25
已完成
不适用
Application of the critical view of safety during laparoscopic cholecystectomyThe patients underwent laparoscopic cholecystectomy.laparoscopic cholecystectomycritical view of safetybile duct injurycomplicationTCTR20210705004/A1,000
已完成
不适用
An Evaluation of the Safety and Performance of the CathVision Cube® SystemCardiac ArrhythmiaNCT05114382CathVision ApS24
进行中（未招募）
不适用
A PILOT STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY AND EFFICACY OF A DAILY DOSE OF 500MG. LU901 (4PHENYL-BUTYRATE, CONTROLLED RELEASE TABLETS) IN ADDITION TO STANDARD HORMONAL TREATMENT IN PATIENTS WITH METASTASIZED PROSTATE CARCINOMA AND A LIFE EXPECTANCY OF AT LEAST 6 MONTHS.Patients suffering from prostate carcinoma with progression underfirst line hormonal treatment. Patients entering the study shouldhave a life expectancy prognosis of at least 6 months.MedDRA version: 12.1Level: LLTClassification code 10007453Term: Carcinoma of the prostate metastaticEUCTR2010-020681-16-DEunamed Operations AG